Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 4/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | AAK1 | Q2M2I8 | 12/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | FPR3 | P25089 | 1/20 | 0.33 |
| ▸ | FPR2 | P25090 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26605089 | 0.90 | GHSR (0.41) | GHSRBACE1NPC1RAB9ARECQL | |
| SCHEMBL30663978 | 0.90 | GHSR (0.41) | GHSRBACE1NPC1RAB9ARECQL | |
| SCHEMBL30758528 | 0.89 | GHSR (0.40) | GHSRBACE1NPC1RAB9ARECQL | |
| SCHEMBL29346209 | 0.89 | GHSR (0.40) | GHSRBACE1NPC1RAB9ARECQL | |
| SCHEMBL31542788 | 0.86 | GHSR (0.41) | GHSRBACE1NPC1RAB9ARECQL | |
| SCHEMBL31240113 | 0.86 | GHSR (0.41) | GHSRBACE1NPC1RAB9ARECQL | |
| SCHEMBL3499937 | 0.84 | GHSR (0.42) | GHSRBACE1NPC1RAB9ARECQL | |
| SCHEMBL31240137 | 0.84 | GHSR (0.42) | GHSRBACE1NPC1RAB9ARECQL | |
| SCHEMBL31542674 | 0.83 | GHSR (0.39) | GHSRBACE1NPC1RAB9ARECQL | |
| SCHEMBL31240233 | 0.83 | GHSR (0.39) | GHSRBACE1NPC1RAB9ARECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250154138-A1 | Small Molecule IL-17A Modulators | BEIGENE, LTD. (KY) | 2025-05-15 | — | — | US | disclosed |
| CN-119053589-A | Small molecule IL-17A modulators | 百济神州有限公司 | 2024-11-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250154138-A1 | Small Molecule IL-17A Modulators | IL17A, IL23R, IL2 | GHSR 3334/4885BACE1 2266/4885NPC1 3783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.